Cargando…
Preclinical Pharmacokinetic Interaction and Histopathological Analyses of Hedyotis diffusa on Sorafenib in Rats
[Image: see text] Sorafenib is one of the most effective target therapeutic agents for patients with late-stage hepatocellular carcinoma. To seek possible alternative adjuvant agents to enhance the efficacy and improve the side effect of sorafenib, Hedyotis diffusa, one of the most prescribed phytom...
Autores principales: | Ting, Chin-Tsung, Cheng, Yung-Yi, Tsai, Tung-Hu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7860071/ https://www.ncbi.nlm.nih.gov/pubmed/33553923 http://dx.doi.org/10.1021/acsomega.0c05461 |
Ejemplares similares
-
Herb-Drug Interaction between the Traditional Hepatoprotective Formulation and Sorafenib on Hepatotoxicity, Histopathology and Pharmacokinetics in Rats
por: Ting, Chin-Tsung, et al.
Publicado: (2017) -
The Antitumor Constituents from Hedyotis Diffusa Willd
por: Wang, Changfu, et al.
Publicado: (2017) -
Mechanism of Hedyotis Diffusa in the Treatment of Cervical Cancer
por: Qian, Kai, et al.
Publicado: (2021) -
Chemical Constituents of Hedyotis diffusa and Their Anti-Inflammatory Bioactivities
por: Hung, Hsin-Yi, et al.
Publicado: (2022) -
The Hedyotis diffusa Willd. (Rubiaceae): A Review on Phytochemistry, Pharmacology, Quality Control and Pharmacokinetics
por: Chen, Rui, et al.
Publicado: (2016)